Tannic Acid Inhibits α-Synuclein Amyloid Fibril Formation via Binding to the Monomer N-terminal Domain
Abstract
-Synuclein (S) is an intrinsically disordered protein (IDP) that aggregates into amyloid fibrils during the progression of Parkinsons Disease and other synucleinopathies. The N-terminal domain (residues 1-60) is now understood to play a critical role in the initial nucleation of aggregation, as well as a pivotal role in the monomer-fibril interaction underlying amyloid seeding. Here we report on the interaction between S and the polyphenol tannic acid (TA), where a combination of solution NMR, atomic force microscopy (AFM), and ThT assays have identified that TA targets the S N-terminal domain to inhibit amyloid fibril formation in a pH dependent manner. This work highlights the importance of targeting the N-terminus of S to arrest fibril formation, and suggests the importance of including polyphenolic moieties in future amyloid inhibitors.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils
- Residues 2-7 of alpha-synuclein regulate amyloid formation via lipid-dependent and -independent pathways
Katherine M. Dewison, Benjamin Rowlinson, … Sheena E. Radford·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 12, 2024
- Suppression and modulation mechanism underlying the flavonoid-induced inhibition of fibrillation of α-synuclein
Geetika Verma, Rajiv Bhat·bioRxiv·Aug 21, 2025
- A structural and kinetic link between membrane association and amyloid fibril formation of α-Synuclein
T. Viennet, M. M. Wördehoff, … M. Etzkorn·bioRxiv·Aug 8, 2017
- An engineered monomer binding-protein for α-synucleinefficiently inhibits the proliferation of amyloid fibrils
E. D. Agerschou, T. Saridaki, … A. K. Buell·bioRxiv·Mar 5, 2019
- N-terminal acetylation reduces α-synuclein pathology in models of Parkinson's disease
Esther del Cid‐Pellitero, Thomas Goiran, … Edward A. Fon·Neurobiology of DiseasePeer-reviewed·Jun 11, 2026